Six issuers began trading this past week, four of which will be included in our stats. The most notable debuts included Corebridge Financial (CRBG) and Third Harmonic Bio (THRD). The pipeline was also active, with seven IPOs...read more
Know Labs, which is developing a non-invasive glucose monitor using biosensor technology, raised $7 million by offering 3.6 million shares at $2, below the last close of its shares on the OTC ($2.53). The company offered 0.6 million more shares than anticipated....read more
Six deals are expected to begin trading in the week ahead, though only five meet the criteria for our IPO stats. The group is led by AIG carve-out Corebridge Financial (CRBG) and biotech Third Harmonic Bio (THRD). In what...read more
Just two small deals are currently on the calendar, though other companies may join the September lineup in the short week ahead. OTC-listed Know Labs (KNW) plans to raise $6 million at a $123 million market cap. Know Labs is focused on...read more
US IPO Weekly Recap: Billion-dollar deal Corebridge completes 2022’s largest IPO to date
Six issuers began trading this past week, four of which will be included in our stats. The most notable debuts included Corebridge Financial (CRBG) and Third Harmonic Bio (THRD). The pipeline was also active, with seven IPOs...read more
Glucose monitor developer Know Labs prices upsized NYSE American uplisting at $2
Know Labs, which is developing a non-invasive glucose monitor using biosensor technology, raised $7 million by offering 3.6 million shares at $2, below the last close of its shares on the OTC ($2.53). The company offered 0.6 million more shares than anticipated....read more
US IPO Week Ahead: Corebridge plots the year’s largest IPO
Six deals are expected to begin trading in the week ahead, though only five meet the criteria for our IPO stats. The group is led by AIG carve-out Corebridge Financial (CRBG) and biotech Third Harmonic Bio (THRD). In what...read more
US IPO Week Ahead: Quiet IPO calendar primed for post-Labor Day launches
Just two small deals are currently on the calendar, though other companies may join the September lineup in the short week ahead. OTC-listed Know Labs (KNW) plans to raise $6 million at a $123 million market cap. Know Labs is focused on...read more